is semaglutide the same as mounjaro Understanding Differences Between and Ozempic Switching from Mounjaro to Wegovy

The American Association for the Study of Liver Diseases (AASLD) acknowledges the potential role of GLP-1 receptor agonists in managing MASLD, particularly in patients with concurrent type 2 diabetes or obesity

doi:10.1016/j.cbpa.2006.11.004

However, panellists also agreed that, in the absence of evidence and clear, consistent guidance, there is a need for an expert-endorsed treatment algorithm, to support clinical decision-making for adults with CKD and T2D

information on active UK trials can be found via the NIHR Be Part of Research platform (bepartofresearch.nihr.ac.uk), the ISRCTN registry (isrctn.com), or the international ClinicalTrials.gov registry